Table 2 Binary and multiple logistic regression model showing determinants of non-adherence to antiretroviral therapy, among adults on ART Aksum town, northern Ethiopia 2015

Sex

 Male

1

1

 Female

1.6 (1.1–2.4)

1.4 (0.8–2.4)

Age

 18–29

1

1

 30–39

1.1 (0.6–2.0)

1.1 (0.5–2.4)

 40–49

1.1 (0.6–2.1)

0.7 (0.3–1.7)

 ≥50

2.3 (1.1–5.2)

1.7 (0.6–5.0)

Residence

 Urban

1

1

 Rural

2.4 (1.3–4.6)

1.4 (0.5–4.0

Occupation

 No occupation

1

1

 Employed

0.9 (0.5–2)

1.4 (0.5–4.2)

 Business

0.8 (0.4–1.6)

1.8 (0.7–4.0)

 Farmer

2.8 (1.1–7.4)

2.3 (0.5–10.3)

 Daily laborer

1 (0.5–1.9)

1.9 (0.8–4.7)

Duration on ART (months)

 6–12

1

1

 13–24

2.0 (0.7–5.5)

2 (0.5–8.8)

 ≥25

3.2 (1.4 7.4)

7 (2.2,22.6)**

ART adverse effect

 Yes

21.2 (6.3–71.3)

6.9 (1.4,32.9)**

 No

1

1

Substance use

 Yes

9.7 (3.6–26.5)

5.3 (1.4–20.0)*

 No

1

1

Live with

 Alone

1

1

 Parents

2.2 (1.02–4.6)

3.4 (1.2–10.3)*

 Family

1.3 (0.8–2.1)

1.5 (0.8–2.8)

Depression status

 Depressed

5.7 (3.2–10.4)

3.3 (1.4–7.5)*

 Not depressed

1

1

CD4 cell count (cells/mm³)

 <350

3.7 (2.4–6.0)

3.2 (1.8–5.8)*

 ≥350

1

1

Dietary diversity

 Low

3.8 (2.4–6.1)

2 (1.1–3.7)*

 Medium and above

1

1

Daily eating pattern

 ≤2 meals

1.7 (1.1–2.6)

1.01 (0.6–1.8)

 ≥3 meals

1

1

Opportunistic infection

 Yes

13.8 (5.2–36.7)

3.6 (1–13.1)

 No

1

1

Reminder use

 Yes

0.3 (0.1–0.8)

0.5 (0.–2.0)

 No

1

1

Stigma

 Yes

3.7 (1.7–8.4)

2.8 (0.9–8.5)

 No

1

1

WHO stage

 Stage I

1

1

 Stage II and above

2.5 (1.4–4.5)

1.6 (0.8–3.5)

BMI

 Under weight

1

1

 Normal

0.5 (0.3–0.8)

0.7 (0.3–1.3)

 Over weight

0.2 (0.1–1.2)

0.4 (0.01–3.0)

Treatment other than ART

 Yes

2.5 (1.5–4.1)

1.4 (0.7–3.0)

 No

1

1